Literature DB >> 26022989

Low-level baroreceptor stimulation suppresses atrial fibrillation by inhibiting ganglionated plexus activity.

Kai Liao1, Lilei Yu1, Xiaoya Zhou1, Gaowa Saren1, Songyu Wang1, Zhuo Wang1, Bing Huang1, Kang Yang1, Hong Jiang2.   

Abstract

BACKGROUND: The autonomic nervous system (ANS) plays an important role in the initiation and maintenance of atrial fibrillation (AF), and modulation of the ANS function may contribute to AF control.
METHODS: Anesthetized dogs received either sham treatment (SHAM group, n = 8) or low-level carotid baroreceptor stimulation (LL-CBS) treatment (LL-CBS group, n = 8). The stimulation voltage was set at 80% below the threshold. To simulate focal AF, high-frequency stimulation (HFS) was applied to local nerves during the atrial refractory period. Multielectrode catheters were attached to the atria and all the pulmonary veins to determine the changes in the AF threshold (AF-TH), the atrial effective refractory period (AERP), and the window of vulnerability (WOV) during HFS in both groups. Microelectrodes were inserted into the anterior right ganglionated plexus (ARGP) to record neural firing.
RESULTS: HFS induced sinus rate (SR) slowing in the superior left ganglionated plexus (SLGP). LL-CBS induced a progressive increase in AF-TH and AERP at all sites and a significant decrease in the sum of WOV at 2 hours (all P < 0.05). LL-CBS inhibited the ability of SLGP stimulation to slow the SR and the mean values of frequency and amplitude of ARGP neural activity compared with the SHAM group (all P < 0.05).
CONCLUSIONS: LL-CBS suppressed AF inducibility by inhibiting the neural activity of ganglionated plexuses. LL-CBS may serve as a novel therapeutic modality to treat AF.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26022989     DOI: 10.1016/j.cjca.2015.01.007

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

Review 1.  New approaches for treating atrial fibrillation: Focus on autonomic modulation.

Authors:  Daniel Sohinki; Stavros Stavrakis
Journal:  Trends Cardiovasc Med       Date:  2019-10-31       Impact factor: 6.677

Review 2.  Cardiac Innervation and the Autonomic Nervous System in Sudden Cardiac Death.

Authors:  William A Huang; Noel G Boyle; Marmar Vaseghi
Journal:  Card Electrophysiol Clin       Date:  2017-12

Review 3.  The nervous heart.

Authors:  Crystal M Ripplinger; Sami F Noujaim; Dominik Linz
Journal:  Prog Biophys Mol Biol       Date:  2016-01-11       Impact factor: 3.667

Review 4.  Neuroscientific therapies for atrial fibrillation.

Authors:  Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

5.  A novel approach to mapping the atrial ganglionated plexus network by generating a distribution probability atlas.

Authors:  Min-Young Kim; Markus B Sikkel; Ross J Hunter; Guy A Haywood; David R Tomlinson; Muzahir H Tayebjee; Rheeda L Ali; Chris D Cantwell; Hanney Gonna; Belinda C Sandler; Elaine Lim; Guy Furniss; Dimitrios Panagopoulos; Gordon Begg; Gurpreet Dhillon; Nicola J Hill; James O'Neill; Darrel P Francis; Phang Boon Lim; Nicholas S Peters; Nick W F Linton; Prapa Kanagaratnam
Journal:  J Cardiovasc Electrophysiol       Date:  2018-10-05

Review 6.  Neuromodulatory Approaches for Atrial Fibrillation Ablation.

Authors:  Moisés Rodríguez-Mañero; Jose Luis Martínez-Sande; Javier García-Seara; Teba González-Ferrero; José Ramón González-Juanatey; Paul Schurmann; Liliana Tavares; Miguel Valderrábano
Journal:  Eur Cardiol       Date:  2021-12-09

Review 7.  Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes.

Authors:  Stavros Stavrakis; Kanchan Kulkarni; Jagmeet P Singh; Demosthenes G Katritsis; Antonis A Armoundas
Journal:  JACC Clin Electrophysiol       Date:  2020-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.